Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab

Riaz, Nadeem, Havel, Jonathan J., Makarov, Vladimir, Desrichard, Alexis, Urba, Walter J., Sims, Jennifer S., Hodi, F. Stephen, Martín-Algarra, Salvador +17 more·2017·Cell

DOI 10.1016/j.cell.2017.09.028

Cited by (1,002)

Items 501–600 of 1,002

Tumor-intrinsic SIRPA promotes sensitivity to checkpoint inhibition immunotherapy in melanoma
Zhicheng Zhou, Mei-Ju May Chen, Yikai Luo, Kamalika Mojumdar, Xin Peng, Hu Chen, Shweta V. Kumar, Rehan Akbani, Yiling Lu, Han Liang · 2022 · Cancer Cell
Targeting PRMT3 impairs methylation and oligomerization of HSP60 to boost anti-tumor immunity by activating cGAS/STING signaling
Yunxing Shi, Zongfeng Wu, Shaoru Liu, Dinglan Zuo, Yi Niu, Yuxiong Qiu, Liang Qiao, Wei A. He, Jiliang Qiu, Yunfei Yuan et al. · 2024 · Nature Communications
Cancer stem cells and tumor-associated macrophages as mates in tumor progression: mechanisms of crosstalk and advanced bioinformatic tools to dissect their phenotypes and interaction
Francesco Verona, Sebastiano Di Bella, Roberto Schirano, Camilla Manfredi, Francesca Angeloro, Giulia Bozzari, Matilde Todaro, Giuseppe Giannini, Giorgio Stassi, Veronica Veschi · 2025 · Frontiers in Immunology
Natural Killer Cells as a Potential Biomarker for Predicting Immunotherapy Efficacy in Patients with Non-Small Cell Lung Cancer
Yong‐Hee Cho, Myeong Geun Choi, Dong Ha Kim, Yun Jung Choi, Seon Ye Kim, Ki Jung Sung, Jae Cheol Lee, Sang‐Yeob Kim, Jin Kyung Rho, Chang‐Min Choi · 2020 · Targeted Oncology
Triggering interferon signaling in T cells with avadomide sensitizes CLL to anti-PD-L1/PD-1 immunotherapy
Nikolaos Ioannou, Patrick Ryan Hagner, Matt Stokes, Anita Krithivas Gandhi, Benedetta Apollonio, Mariam Fanous, Despoina Papazoglou, Lesley‐Ann Sutton, Richard Rosenquist, Rose‐Marie Amini et al. · 2020 · Blood
Improving anti-PD-L1 therapy in triple negative breast cancer by polymer-enhanced immunogenic cell death and CXCR4 blockade
Minglu Zhou, Chaohui Luo, Zhou Zhou, Lian Li, Yuan Huang · 2021 · Journal of Controlled Release
Association of PTPRT mutations with immune checkpoint inhibitors response and outcome in melanoma and non‐small cell lung cancer
Wenjing Zhang, Fuyan Shi, Yujia Kong, Yuting Li, Chao Sheng, Suzhen Wang, Qinghua Wang · 2021 · Cancer Medicine
Intratumor Heterogeneity and Antitumor Immunity Shape One Another Bidirectionally
Yochai Wolf, Yardena Samuels · 2022 · Clinical Cancer Research
Clinically oriented prediction of patient response to targeted and immunotherapies from the tumor transcriptome
Gal Dinstag, Eldad David Shulman, Efrat Elis, Doreen S. Ben-Zvi, Omer Tirosh, Eden Maimon, Isaac Meilijson, Emmanuel Elalouf, Boris Temkin, Philipp Vitkovsky et al. · 2022 · Med
The landscape of objective response rate of anti-PD-1/L1 monotherapy across 31 types of cancer: a system review and novel biomarker investigating
Yize Mao, Hui Xie, Min‐Yi Lv, Qiuxia Yang, Zeyu Shuang, Feng Gao, Shengping Li, Lina Zhu, Wei Wang · 2023 · Cancer Immunology Immunotherapy
Human papillomavirus-encoded circular RNA circE7 promotes immune evasion in head and neck squamous cell carcinoma
Junshang Ge, Yi Meng, Jiayue Guo, Pan Chen, Jie Wang, Lei Shi, Dan Wang, Hongke Qu, Pan Wu, Chunmei Fan et al. · 2024 · Nature Communications
Biosynthetic energy cost for amino acids decreases in cancer evolution
Hong Zhang, Yirong Wang, Jun Li, Han Chen, Xionglei He, Huiwen Zhang, Han Liang, Jian Lü · 2018 · Nature Communications
RNA Sequencing of the Tumor Microenvironment in Precision Cancer Immunotherapy
Denise Lau, Alexandria M. Bobe, Aly Azeem Khan · 2019 · Trends in cancer
Immunotherapy for head and neck cancer: where are we now and where are we going?
J. Bauml, C. Aggarwal, R. Cohen · 2019 · Annals of Translational Medicine
Identification of an immune gene expression signature associated with favorable clinical features in Treg-enriched patient tumor samples
Kevin Bijan Givechian, Kamil Wnuk, Chad P. Garner, Stephen Charles Benz, Hermes Garbán, Shahrooz Rabizadeh, Kayvan Niazi, Patrick Soon‐Shiong · 2018 · npj Genomic Medicine
Biomarkers for Predicting Efficacies of Anti-PD1 Antibodies
Yumi Kambayashi, Taku Fujimura, Takanori Hidaka, Setsuya Aiba · 2019 · Frontiers in Medicine
Tumour mutational burden: primary versus metastatic tissue creates systematic bias
Désirée Schnidrig, Samra Turajlic, Kevin Litchfield · 2019 · Immuno-Oncology Technology
The immune-related role of beta-2-microglobulin in melanoma
Chuqiao Wang, Zeqi Wang, Tengteng Yao, Jibo Zhou, Zhaoyang Wang · 2022 · Frontiers in Oncology
ICBatlas: A Comprehensive Resource for Depicting Immune Checkpoint Blockade Therapy Characteristics from Transcriptome Profiles
Mei Yang, Ya‐Ru Miao, Gui‐Yan Xie, Mei Luo, Hui Hu, Hang Fai Kwok, Jian Feng, An‐Yuan Guo · 2022 · Cancer Immunology Research
Virtual clinical trials of anti-PD-1 and anti-CTLA-4 immunotherapy in advanced hepatocellular carcinoma using a quantitative systems pharmacology model
Richard J. Sové, Babita K. Verma, Hanwen Wang, Won Jin Ho, Mark M. Yarchoan, Aleksander S. Popel · 2022 · Journal for ImmunoTherapy of Cancer
ZNF689 deficiency promotes intratumor heterogeneity and immunotherapy resistance in triple-negative breast cancer
Li‐Ping Ge, Xi Jin, Ding Ma, Zi-Yu Wang, Chenglin Liu, Chaozheng Zhou, Shen Zhao, Tian‐Jian Yu, Xiyu Liu, Gen Hong Di et al. · 2024 · Cell Research
Pan-cancer evaluation of regulated cell death to predict overall survival and immune checkpoint inhibitor response
Wei Zhang, Yongwei Zhu, Hongyi Liu, Yihao Zhang, Hongwei Liu, Abraham Ayodeji Adegboro, Ruiyue Dang, Luohuan Dai, Siyi Wanggou, Xuejun Li · 2024 · npj Precision Oncology
Analysis of PD1, LAG3, TIGIT, and TIM3 expression in human lung adenocarcinoma reveals a 25-gene signature predicting immunotherapy response
Jean‐Philippe Guégan, Florent Peyraud, Bérengère Dadone‐Montaudié, Diego Teyssonneau, Lola‐Jade Palmieri, Emma Clot, Sophie Cousin, Guilhem Roubaud, Mathilde Cabart, Laura Leroy et al. · 2024 · Cell Reports Medicine
Tumor neoantigenicity assessment with CSiN score incorporates clonality and immunogenicity to predict immunotherapy outcomes
Tianshi Lu, Shidan Wang, Lin Xu, Qinbo Zhou, Nirmish Singla, Jianjun Gao, Subrata Manna, Laurentiu M. Pop, Zhiqun Xie, Mingyi Chen et al. · 2020 · Science Immunology
Progress in Neoantigen Targeted Cancer Immunotherapies
Xuejiao Han, Xuelei Ma, Yang Li, Yu-quan Wei, Yong Peng, Xiawei Wei · 2020 · Frontiers in Cell and Developmental Biology
The methods and advances of adaptive immune receptors repertoire sequencing
Hongmei Liu, Wenjing Pan, Congli Tang, Yujie Tang, Haijing Wu, Akihiko Yoshimura, Yan Deng, Nongyue He, Song Li · 2021 · Theranostics
Cancer-Specific Immune Prognostic Signature in Solid Tumors and Its Relation to Immune Checkpoint Therapies
Shaoli Das, Kevin A. Camphausen, Uma T. Shankavaram · 2020 · Cancers
PD-L1 and ICOSL discriminate human Secretory and Helper dendritic cells in cancer, allergy and autoimmunity
Caroline Hoffmann, Floriane Noël, Maximilien Grandclaudon, Lucile Massenet-Regad, Paula Michea, Philémon Sirven, Lilith Faucheux, Aurore Surun, Olivier J Lantz, Mylène Bohec et al. · 2022 · Nature Communications
The proteasome regulator PSME4 modulates proteasome activity and antigen diversity to abrogate antitumor immunity in NSCLC
Aaron Javitt, Merav D. Shmueli, Matthias P. Kramer, Aleksandra A. Kolodziejczyk, Ivan Cohen, Lihi Radomir, Daoud Sheban, Iris Kamer, Kevin Litchfield, Elizabeta Bab-Dinitz et al. · 2023 · Nature Cancer
Senescence-induced immune remodeling facilitates metastatic adrenal cancer in a sex-dimorphic manner
Kate M. Warde, Lorenzo Smith, Lihua Liu, Chris Stubben, Brian K. Lohman, Parker W. Willett, Julia L. Ammer, Guadalupe Castaneda-Hernandez, Sikiru O. Imodoye, Chenge Zhang et al. · 2023 · Nature Aging
Tumor monocyte content predicts immunochemotherapy outcomes in esophageal adenocarcinoma
Thomas M. Carroll, Joseph A. Chadwick, Richard P. Owen, Michael Joseph White, Joseph Kaplinsky, Iliana Peneva, Anna Frangou, Phil F. Xie, Jaeho Chang, Andrew J. L. Roth et al. · 2023 · Cancer Cell
Melanoma: Genetic Abnormalities, Tumor Progression, Clonal Evolution and Tumor Initiating Cells
Ugo Testa, Germana Castelli, Elvira Pelosi · 2017 · Medical Sciences
Possible Biomarkers for Cancer Immunotherapy
Takehiro Otoshi, Tatsuya Nagano, Motoko Yoshikawa TACHIHARA, Yoshihiro Nishimura · 2019 · Cancers
Decoding Immune Heterogeneity of Triple Negative Breast Cancer and Its Association with Systemic Inflammation
Sandra Lorena Romero-Cordoba, Elisabetta Meneghini, Milena Sant, Marilena Valeria Iorio, Lucia Sfondrini, Biagio Paolini, Roberto Agresti, Elda Tagliabue, Francesca Bianchi · 2019 · Cancers
In situ vaccination with defined factors overcomes T cell exhaustion in distant tumors
Danny N. Khalil, Nathan Suek, Luís Felipe Campesato, Sadna Budhu, David Redmond, Robert M. Samstein, Chirag Krishna, Katherine S. Panageas, Marinela Capanu, Sean Houghton et al. · 2019 · Journal of Clinical Investigation
Analysis of DNA methylation patterns in the tumor immune microenvironment of metastatic melanoma
Shamik Mitra, Martin Lauss, Rita Cabrita, Jiyeon Choi, Tongwu Zhang, Karolin Isaksson, Hakan Lars Olsson, Christian Ingvar, Ana Carneiro, Johan Staaf et al. · 2020 · Molecular Oncology
Modern Aspects of Immunotherapy with Checkpoint Inhibitors in Melanoma
Vera Petrova, Ihor Arkhypov, Rebekka Weber, Christopher Groth, Peter Altevogt, Jochen Sven Utikal, Viktor Umansky · 2020 · International Journal of Molecular Sciences
Tumor Extracellular Vesicles Regulate Macrophage-Driven Metastasis through CCL5
Daniel C. Rabe, Nykia D. Walker, Felicia D Rustandy, Jessica Wallace, Jiyoung Lee, Shannon L. Stott, M. Rosner · 2021 · Cancers
Pathway signatures derived from on-treatment tumor specimens predict response to anti-PD1 blockade in metastatic melanoma
Kuang Du, Shiyou Wei, Zhi Wei, Dennie Tompers Frederick, Benchun Miao, Tabea O. C. Moll, Tian Tian, Eric T. Sugarman, Dmitry I. Gabrilovich, Ryan Joseph Sullivan et al. · 2021 · Nature Communications
Profiling of immune features to predict immunotherapy efficacy
Youqiong Ye, Yongchang Zhang, Nong Yang, Qian Gao, Xinyu Ding, Xinwei Kuang, Rujuan Bao, Zhao Zhang, Chaoyang Sun, Bingying Zhou et al. · 2021 · The Innovation
Prognostic Value of Neoantigen Load in Immune Checkpoint Inhibitor Therapy for Cancer
Xue-lin Zou, Xiaobo Li, Hua Ke, Guangyan Zhang, Qing Tang, Jiao Yuan, Chen-jiao Zhou, Jiliang Zhang, Rui Zhang, Wei-yong Chen · 2021 · Frontiers in Immunology
Immune Determinants of the Association between Tumor Mutational Burden and Immunotherapy Response across Cancer Types
Neelam Sinha, Sanju Sinha, Cristina Valero, Alejandro A. Schäffer, Kenneth Aldape, Kevin Litchfield, Timothy A Chan, Luc G T Morris, Eytan Ruppin · 2022 · Cancer Research
Cancer Cell Phenotype Plasticity as a Driver of Immune Escape in Melanoma
Valentin Benboubker, Félix Boivin, Stéphane Dalle, Julie Caramel · 2022 · Frontiers in Immunology
Mechanisms of Immunotherapy Resistance in Cutaneous Melanoma: Recognizing a Shapeshifter
Jessica Thornton, Gagan Chhabra, Chandra K. Singh, Glorimar Guzmán‐Pérez, Carl A. Shirley, Nihal Ahmad · 2022 · Frontiers in Oncology
Machine learning identifies T cell receptor repertoire signatures associated with COVID-19 severity
Jonathan Joon-Young Park, Kyoung A. Viola Lee, Stanley Z. Lam, Katherine S. Moon, Zhenhao Fang, Sidi Chen · 2023 · Communications Biology
Integrated molecular drivers coordinate biological and clinical states in melanoma
Jake R. Conway, Felix Dietlein, Amaro N Taylor-Weiner, Saud H. AlDubayan, Natalie I. Vokes, Tanya Elizabeth Keenan, Brendan Michael Reardon, Meng Xiao He, Claire A. Margolis, Jason L. Weirather et al. · 2020 · Nature Genetics
Photothermal Nano-Vaccine Promoting Antigen Presentation and Dendritic Cells Infiltration for Enhanced Immunotherapy of Melanoma via Transdermal Microneedles Delivery
Jiaojiao Zhu, Ruimin Chang, Benliang Wei, Yao Shi Fu, Xiang Chen, Hong Liu, Wenhu Zhou · 2022 · Research
BND-22, a first-in-class humanized ILT2-blocking antibody, promotes antitumor immunity and tumor regression
Ilana Mandel, Dana Haves Ziv, Ilana Goldshtein, Tsuri Peretz, Dror Alishekevitz, Anna Fridman Dror, Motti Hakim, Sharon Hashmueli, Itay Friedman, Yair Sapir et al. · 2022 · Journal for ImmunoTherapy of Cancer
The prognostic and biology of tumour-infiltrating lymphocytes in the immunotherapy of cancer
Yanbin Liu, Zhenjiang Liu, Yixiao Yang, Jingwei Sun, Jingwei Sun, Yarong Liu · 2023 · British Journal of Cancer
Deciphering lung adenocarcinoma evolution: Integrative s ingle‐cell genomics identifies the prognostic lung progression associated signature
Pengpeng Zhang, Zijun Yang, Liu Zuo, Ge Zhang, Lianmin Zhang, Zhenfa Zhang, Jun Fan · 2024 · Journal of Cellular and Molecular Medicine
Neoantigen immunogenicity landscapes and evolution of tumor ecosystems during immunotherapy with nivolumab
Tyler Joseph Alban, Nadeem Riaz, Prerana Bangalore Parthasarathy, Vladimir Makarov, Sviatoslav M. Kendall, Seong‐Keun Yoo, Rachna Shah, Nils Weinhold, Raghvendra Mohan Srivastava, Xiaoxiao Ma et al. · 2024 · Nature Medicine
Tumor antigens preferentially derive from unmutated genomic sequences in melanoma and non-small cell lung cancer
Anca Apavaloaei, Qingchuan Zhao, Leslie Hesnard, Maxime Cahuzac, Chantal Durette, Jean‐David Larouche, Marie‐Pierre Hardy, Krystel Vincent, Sylvie Brochu, Jean‐Philippe Laverdure et al. · 2025 · Nature Cancer
STAT3 as a potential immunotherapy biomarker in oncogene-addicted non-small cell lung cancer
Ilaria Attili, Niki Karachaliou, Laura Bonanno, Jordi Berenguer, Jillian Wilhelmina Paulina Bracht, Jordi Codony‐Servat, Carles Codony, Masaoki Ito, Rafael Rosell · 2018 · Therapeutic Advances in Medical Oncology
T-cell-based breast cancer immunotherapy
Karolina Pilipow, Abbass Darwich, Agnese Losurdo · 2020 · Seminars in Cancer Biology
Current status and future perspectives of immunotherapy in bladder cancer treatment
Zhangsong Wu, Jinjian Liu, Ruixiang Dai, Song Wu · 2020 · Science China Life Sciences
9-Gene Signature Correlated With CD8+ T Cell Infiltration Activated by IFN-γ: A Biomarker of Immune Checkpoint Therapy Response in Melanoma
Kexin Yan, Yuxiu Lu, Zhangyong Yan, Yutao Wang · 2021 · Frontiers in Immunology
Genetic Intratumor Heterogeneity Remodels the Immune Microenvironment and Induces Immune Evasion in Brain Metastasis of Lung Cancer
Xin Wang, Hua Bai, Jiyang Zhang, Zhijie Wang, Jianchun Duan, Hong‐Qing Cai, Zheng Cao, Lin Q, Xiaosheng Ding, Yiting Sun et al. · 2023 · Journal of Thoracic Oncology
Neoadjuvant tislelizumab plus stereotactic body radiotherapy and adjuvant tislelizumab in early-stage resectable hepatocellular carcinoma: the Notable-HCC phase 1b trial
Zhongchao Li, Jing Liu, Bo Zhang, Jinbo Yue, Xuetao Shi, Kai Cui, Zhaogang Liu, Zhibin Chang, Zhicheng Sun, Mingming Li et al. · 2024 · Nature Communications
Tumor-associated macrophage clusters linked to immunotherapy in a pan-cancer census
Chen Wei, Yijie Ma, Mengyu Wang, Siyi Wang, Wenyue Yu, Shuailei Dong, Wenying Deng, Liangyu Bie, Chi Zhang, Wei Shen et al. · 2024 · npj Precision Oncology
Adoptive T Cell Therapy: New Avenues Leading to Safe Targets and Powerful Allies
Dora Hammerl, Dietmar Rieder, John W.M. Martens, Zlatko Trajanoski, Reno Debets · 2018 · Trends in Immunology
Rationale of Immunotherapy in Hepatocellular Carcinoma and Its Potential Biomarkers
David Wai-Meng Tai, Su Pin Choo, Valerie Chew · 2019 · Cancers
A Novel Immune-Related Prognostic Model for Response to Immunotherapy and Survival in Patients With Lung Adenocarcinoma
Yujia Zheng, He Tian, Zheng Zhou, Chu Xiao, Hengchang Liu, Yu Liu, Liyu Wang, Tao T. Fan, Bo Jian Zheng, Fengwei Tan et al. · 2021 · Frontiers in Cell and Developmental Biology
Senescence as a dictator of patient outcomes and therapeutic efficacies in human gastric cancer
Lulin Zhou, Zubiao Niu, Yuqi Wang, You Yi Zheng, Yichao Zhu, Chenxi Wang, Xiaoyan Gao, Lihua Gao, Wen Zhang, Kaitai Zhang et al. · 2022 · Cell Death Discovery
T cell receptor convergence is an indicator of antigen-specific T cell response in cancer immunotherapies
Mingyao Pan, Bo Li · 2022 · eLife
DNASE1L3-expressing dendritic cells promote CD8+ T cell function and anti-PD-(L)1 therapy efficacy by degrading neutrophil extracellular traps
Degao Chen, Zheng Jin, Chu Han, Yucui Wu, Yangping Bian, Ting Yuan, Hao Lv, Qiuyu Xia, Lei Wang, Qian Chu et al. · 2025 · Cancer Cell
Engineering Vaccines to Reprogram Immunity against Head and Neck Cancer
Yee-Sun Tan, K. Sansanaphongpricha, M. Prince, Du-Xin Sun, G. Wolf, Y. Lei · 2018 · Journal of dentistry research
Emerging Blood-Based Biomarkers for Predicting Response to Checkpoint Immunotherapy in Non-Small-Cell Lung Cancer
Shumin Li, Chengyan Zhang, Guanchao Pang, Pingli Wang · 2020 · Frontiers in Immunology
Blood tumor mutation burden can predict the clinical response to immune checkpoint inhibitors in advanced non-small cell lung cancer patients
Xi Chen, Liangjie Fang, Yan‐Ping Zhu, Zhang Bao, Qing Wang, Rong Liu, Wenjia Sun, Haiwei Du, Jing Lin, Bing Yu et al. · 2021 · Cancer Immunology Immunotherapy
Safety and Efficacy of Personalized Cancer Vaccines in Combination With Immune Checkpoint Inhibitors in Cancer Treatment
Juan-Yan Liao, Shuang Zhang · 2021 · Frontiers in Oncology
Ipilimumab alone or in combination with nivolumab in patients with advanced melanoma who have progressed or relapsed on PD-1 blockade: clinical outcomes and translational biomarker analyses
Claire Frances Friedman, Christine N. Spencer, Christopher R. Cabanski, Katherine S. Panageas, Daniel K. Wells, Antoni Ribas, Hussein A. Tawbi, Katy K. Tsai, Michael Andrew Postow, Alexander Noor Shoushtari et al. · 2022 · Journal for ImmunoTherapy of Cancer
Pan-cancer analysis implicates novel insights of lactate metabolism into immunotherapy response prediction and survival prognostication
Dongjie Chen, Pengyi Liu, Xiongxiong Lu, Jingfeng Li, Debin Qi, Longjun Zang, Jiayu Lin, Yihao Liu, Shuyu Zhai, Da Fu et al. · 2024 · Journal of Experimental & Clinical Cancer Research
Neoadjuvant sintilimab plus chemotherapy in EGFR-mutant NSCLC: Phase 2 trial interim results (NEOTIDE/CTONG2104)
Chao Zhang, Yu-Xuan Sun, Dingcheng Yi, Ben‐Yuan Jiang, Li‐Xu Yan, Ze-Dao Liu, Lishan Peng, Wenjie Zhang, Hao Sun, Zhiyong Chen et al. · 2024 · Cell Reports Medicine
Potential predictive biomarkers in antitumor immunotherapy: navigating the future of antitumor treatment and immune checkpoint inhibitor efficacy
Xiangyu Yin, Xue Song, Wanglong Deng, NEIL W. BLAKE, Xinghong Luo, Jia Meng · 2024 · Frontiers in Oncology
PRMT3 drives PD-L1-mediated immune escape through activating PDHK1-regulated glycolysis in hepatocellular carcinoma
Chen‐Hong Ding, Fang‐Zhi Yan, Binghe Xu, Hui Qian, Xia-Lu Hong, Shuqing Liu, Yuanyuan Luo, Sihan Wu, Ling-Yan Cai, Xin Zhang et al. · 2025 · Cell Death and Disease
Identification and Characterization of Neoantigens As Well As Respective Immune Responses in Cancer Patients
Eva Bräunlein, Angela M. Krackhardt · 2017 · Frontiers in Immunology
mTOR at the Transmitting and Receiving Ends in Tumor Immunity
Yakir Guri, Thierry M. Nordmann, Jason Roszik · 2018 · Frontiers in Immunology
Carbohydrate Targets for CAR T Cells in Solid Childhood Cancers
Claudia Rössig, Sareetha Kailayangiri, Silke Jamitzky, Bianca Altvater · 2018 · Frontiers in Oncology
RNase H–dependent PCR-enabled T-cell receptor sequencing for highly specific and efficient targeted sequencing of T-cell receptor mRNA for single-cell and repertoire analysis
Shuqiang Li, Jing Sun, Rosa Lundbye Allesøe, Krishnalekha Datta, Yun Bao, Giacomo Oliveira, Juliet Forman, Roger Jin, Lars Rønn Olsen, Derin B. Keskin et al. · 2019 · Nature Protocols
Enhanced B7-H4 expression in gliomas with low PD-L1 expression identifies super-cold tumors
Di Chen, Gaopeng Li, Chunxia Ji, Qiqi Lu, Ying Qi, Chao Tang, Ji Xiong, JIAN LI HU, Fatma Betul Aksoy Yasar, Yan Zhang et al. · 2020 · Journal for ImmunoTherapy of Cancer
Multiplexed imaging mass cytometry reveals distinct tumor-immune microenvironments linked to immunotherapy responses in melanoma
Xiao Xu, Qian Guo, Chuanliang Cui, Yating Lin, Lei Justan Zhang, Xin Ding, Qiyuan Li, Minshu Wang, Wenxian Yang, Yan Kong et al. · 2022 · Communications Medicine
Antitumor Immune Responses in B2M -Deficient Cancers
Davis Yuri Torrejon, Mildred Galvez, Gabriel Abril-Rodríguez, Katie Marie Campbell, Egmidio Medina, Agustin Vega-Crespo, Anusha K. Kalbasi, Begoña Comı́n-Anduix, Antoni Ribas · 2023 · Cancer Immunology Research
Uveal melanoma immunogenomics predict immunotherapy resistance and susceptibility
Shravan Leonard‐Murali, Chetana Bhaskarla, Ghanshyam Singh Yadav, Sudeep K. Maurya, Chenna R. Galiveti, Joshua A. Tobin, Rachel J. Kann, Eishan Ashwat, Patrick S. Murphy, Anish Bhaswanth Chakka et al. · 2024 · Nature Communications
Emerging Strategies in Systemic Therapy for the Treatment of Melanoma
Paolo A. Ascierto, Keith T. Flaherty, Stephanie L. Goff · 2018 · American Society of Clinical Oncology Educational Book
IL-32γ potentiates tumor immunity in melanoma
Thomas Gruber, Mirela Kremenovic, Hassan Sadozai, Nives Rombini, Lukas Bäriswyl, Fabienne Maibach, Robert L. Modlin, Michel F. Gilliet, Diego von Werdt, Robert Emil Hunger et al. · 2020 · JCI Insight
Integrating Circulating Biomarkers in the Immune Checkpoint Inhibitor Treatment in Lung Cancer
Boris Duchemann, Jordi Remón, Marie Naigeon, Laura Mezquita, Roberto Ferrara, Lydie Cassard, Jean-Mehdi Jouniaux, Lisa Boselli, Jonathan Grivel, Édouard Auclin et al. · 2020 · Cancers
Combining a Universal Telomerase Based Cancer Vaccine With Ipilimumab in Patients With Metastatic Melanoma - Five-Year Follow Up of a Phase I/IIa Trial
Elin Aamdal, Else Marit Inderberg, Espen B. Ellingsen, Wenche Rasch, Paal Fredrik Brunsvig, Steinar Aamdal, Karen‐Marie Heintz, Daniel Vodák, Sigve Nakken, Eivind J. Hovig et al. · 2021 · Frontiers in Immunology
Multi-omics Analysis of Ferroptosis Regulation Patterns and Characterization of Tumor Microenvironment in Patients with Oral Squamous Cell Carcinoma
Wenchao Gu, Mai Kim, Lei Wang, Zongcheng Yang, Takahito Nakajima, Yoshito Tsushima · 2021 · International Journal of Biological Sciences
Barriers to Immunotherapy in Ovarian Cancer: Metabolic, Genomic, and Immune Perturbations in the Tumour Microenvironment
Racheal Louise Johnson, Michele Cummings, Amudha Thangavelu, Georgios Theophilou, Diederick De Jong, Nicolas Michel Orsi · 2021 · Cancers
Advancements in Cancer Immunotherapies
Ruchi Roy, Sunil Kumar Singh, Sweta Misra · 2022 · Vaccines
Innate immune checkpoint inhibitor resistance is associated with melanoma sub-types exhibiting invasive and de-differentiated gene expression signatures
Sultana Mehbuba Hossain, Grégory Gimenez, Peter A. Stockwell, Peter Tsai, Cristin Gregor Print, Janusz Ryś, Bożena Cybulska-Stopa, Magdalena Ratajska, Agnieszka Harazin-Lechowska, Suzan N. Almomani et al. · 2022 · Frontiers in Immunology
A comprehensive analysis of PANoptosome to prognosis and immunotherapy response in pan-cancer
Lingling Zhuang, Qiran Sun, Shenglan Huang, Lanyan Hu, Qi Chen · 2023 · Scientific Reports
High-Throughput Screening of Combinatorial Immunotherapies with Patient-Specific In Silico Models of Metastatic Colorectal Cancer
Jakob Nikolas Kather, Pornpimol Charoentong, Meggy Suarez‐Carmona, Esther Herpel, Fee Klupp, Alexis B. Ulrich, Martin Schneider, Inka Zoernig, Tom Luedde, Dirk Jaeger et al. · 2018 · Cancer Research
Computational approaches for characterizing the tumor immune microenvironment
Candace C. Liu, Chloé Beate Steen, Aaron M. Newman · 2019 · Immunology
Ginsenoside Rh2 Improves the Cisplatin Anti-tumor Effect in Lung Adenocarcinoma A549 Cells via Superoxide and PD-L1
Yingying Chen, Yuqiang Zhang, Wei Song, Ying Zhang, Dong Xiu, Mingqi Tan · 2019 · Anti-Cancer Agents in Medicinal Chemistry
Integration of Omics Data Sources to Inform Mechanistic Modeling of Immune‐Oncology Therapies: A Tutorial for Clinical Pharmacologists
Georgia Lazarou, Vijayalakshmi Chelliah, Ben G. Small, Michael Walker, Piet H. van der Graaf, Andrzej M. Kierzek · 2020 · Clinical Pharmacology & Therapeutics
Dynamics of peripheral T cell clones during PD-1 blockade in non-small cell lung cancer
Fan Zhang, Hua Bai, Ranran Gao, Kailun Fei, Jianchun Duan, Zemin Zhang, Jie Wang, Xueda Hu · 2020 · Cancer Immunology Immunotherapy
Impact of cancer evolution on immune surveillance and checkpoint inhibitor response
Yin Wu, Dhruva Biswas, Charles Swanton · 2021 · Seminars in Cancer Biology
Emerging dynamics pathways of response and resistance to PD-1 and CTLA-4 blockade: tackling uncertainty by confronting complexity
Allan Relecom, Maysaloun Merhi, Varghese Philipose Inchakalody, Shahab Uddin M.S., Darawan Rinchai, Davide Bedognetti, Said Dermime · 2021 · Journal of Experimental & Clinical Cancer Research
Immune deserts in head and neck squamous cell carcinoma: A review of challenges and opportunities for modulating the tumor immune microenvironment
Janice L. Farlow, John Chad Brenner, Yu L. Lei, Steven Bennett Chinn · 2021 · Oral Oncology
A balance score between immune stimulatory and suppressive microenvironments identifies mediators of tumour immunity and predicts pan-cancer survival
Tolga Turan, Sarah Kongpachith, Kyle D. Halliwill, Jessica P Roelands, Wouter Hendrickx, Francesco Maria Marincola, Thomas J. Hudson, Howard J. Jacob, Davide Bedognetti, Josue A. Samayoa et al. · 2020 · British Journal of Cancer